Ventilation Strategy for ARDS with Status Asthmaticus and Type 2 Respiratory Failure
Use lung-protective ventilation with tidal volumes of 4-8 mL/kg predicted body weight and plateau pressures ≤30 cmH₂O for all patients with ARDS, regardless of concurrent asthma or hypercapnia. 1, 2, 3
Core Ventilation Parameters
Volume Settings:
- Set tidal volume at 6 mL/kg predicted body weight (acceptable range 4-8 mL/kg PBW) 1, 2, 3
- Calculate predicted body weight: Males = 50 + 0.91 × [height (cm) - 152.4] kg; Females = 45.5 + 0.91 × [height (cm) - 152.4] kg 2, 3
- Never exceed 8 mL/kg PBW even if plateau pressures appear acceptable—both parameters must be optimized simultaneously 2, 3
Pressure Targets:
- Maintain plateau pressure ≤30 cmH₂O as an absolute ceiling 1, 2, 3
- Target driving pressure (plateau pressure - PEEP) ≤15 cmH₂O—this predicts mortality better than tidal volume or plateau pressure alone 2
- Accept permissive hypercapnia with pH >7.20 as a consequence of lung protection 3
PEEP Strategy Based on ARDS Severity
For Moderate-to-Severe ARDS (PaO₂/FiO₂ <200 mmHg):
- Use higher PEEP (typically >10 cmH₂O) 1, 2, 3
- Higher PEEP reduces mortality in this population (adjusted RR 0.90) 2
- This recommendation takes precedence despite concerns about air trapping in asthma 1, 4
For Mild ARDS (PaO₂/FiO₂ 200-300 mmHg):
Critical Consideration for Asthma Component:
- Set PEEP between 4-8 cmH₂O initially to counteract auto-PEEP and improve ventilator triggering 5
- Monitor closely for auto-PEEP and dynamic hyperinflation 5
- Allow adequate expiratory time (I:E ratio approximately 1:2 or 1:3) to prevent air trapping 5
Prone Positioning for Severe ARDS
For severe ARDS with PaO₂/FiO₂ <150 mmHg:
- Implement prone positioning immediately for at least 12-16 hours daily—this is a strong recommendation that reduces mortality (RR 0.74) 1, 2, 3
- Do not delay prone positioning even with concurrent asthma—early implementation improves outcomes 3
Managing the Dual Pathophysiology
The ARDS component dominates management priorities:
- Lung-protective ventilation prevents ventilator-induced lung injury which worsens both ARDS and outcomes 1, 4
- The inflammatory pulmonary edema of ARDS requires low tidal volumes regardless of underlying asthma 1
Addressing the asthma/obstructive component:
- Monitor for auto-PEEP by checking end-expiratory flow and pressure-time waveforms 5
- Adjust expiratory time to allow complete exhalation 5
- Bronchodilator therapy should continue but does not change core ventilation strategy 3
Managing Type 2 Respiratory Failure (Hypercapnia):
- Accept permissive hypercapnia as necessary to maintain lung-protective ventilation 3, 4
- Maintain pH >7.20 rather than normalizing PaCO₂ 3
- Do not increase tidal volumes above 8 mL/kg PBW to correct hypercapnia—this causes more harm than the hypercapnia itself 2, 3
Additional Interventions
Neuromuscular Blockade:
- For early severe ARDS with PaO₂/FiO₂ <150 mmHg, use neuromuscular blocking agents for up to 48 hours 2, 3
Corticosteroids:
- Administer systemic corticosteroids to mechanically ventilated patients with ARDS 2, 3
- This addresses both ARDS inflammation and asthma exacerbation 2
Fluid Management:
Oxygenation Targets:
Critical Pitfalls to Avoid
Do not prioritize normocapnia over lung protection:
- Increasing tidal volumes to correct hypercapnia will worsen ventilator-induced lung injury and increase mortality 2, 3
- The type 2 respiratory failure is managed with permissive hypercapnia, not higher tidal volumes 3, 4
Do not use excessive tidal volumes despite obstructive physiology:
- Even with concurrent asthma, tidal volumes >8 mL/kg PBW cause harm in ARDS 2, 3
- The temptation to use larger tidal volumes for "stiff lungs" or to overcome obstruction must be resisted 1, 4
Do not use high-frequency oscillatory ventilation:
Do not perform aggressive or prolonged recruitment maneuvers:
Monitor for barotrauma: